YESCARTA® may be an option when other treatments fail

The treatment that’s right for you can depend on the type of lymphoma you have, your overall health, the number of different treatments you have tried so far, and your personal preferences. In some cases, the cancer is slow to spread and grow, while others are more aggressive and require several lines of treatment. If this happens, it's important to know early on that you will have options.

Whether your follicular lymphoma is considered indolent or high risk, YESCARTA may be an option after 2 other kinds of treatment fail.

Indolent Lymphoma

Follicular lymphoma (FL) is a type of indolent non-Hodgkin lymphoma. They are often considered slow-growing cancers. This is why you may have started with a watch-and-wait-approach to treatment where you are carefully monitored to see if signs of cancer progress.

High-Risk Lymphoma

For some people, FL can be more aggressive. Your cancer may have resisted treatment, involve multiple lymph nodes, or returned within 2 years of your first treatment.